help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1338
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/2/485    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffen, S. C.
Right arrow Articles by Havel, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffen, S. C.
Right arrow Articles by Havel, P. J.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Female Endocrinology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 2 485-491
Copyright © 2006 by The Endocrine Society

Administration of Lispro Insulin with Meals Improves Glycemic Control, Increases Circulating Leptin, and Suppresses Ghrelin, Compared with Regular/NPH Insulin in Female Patients with Type 1 Diabetes

Steven C. Griffen, Kimberly Oostema, Kimber L. Stanhope, James Graham, Dennis M. Styne, Nicole Glaser, David E. Cummings, Matthew H. Connors and Peter J. Havel

Department of Endocrinology (S.C.G.) and Pediatrics (D.M.S., N.G., M.H.C.), School of Medicine, and Department of Nutrition (K.O., K.L.S., J.G., P.J.H.), University of California, Davis, Davis, California 95616; and Division of Endocrinology (D.E.C.), University of Washington Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108

Address all correspondence to: Steven C. Griffen, University of California, Davis, Medical Center, Patient Support and Services Building Suite G-400, 4150 V Street, Sacramento, California 95817. E-mail: scgriffen{at}ucdavis.edu.

Context: Overweight and obesity are overrepresented in adolescents with type 1 diabetes mellitus (T1DM). Exogenous insulin administration often poorly reproduces normal insulin patterns and may less effectively regulate leptin and ghrelin, two hormones involved in the control of appetite and adiposity.

Objective: The objective of the study was to determine whether insulin regimens that better replicate normal insulin patterns and augment postprandial nutrient disposal may help normalize leptin and ghrelin and improve body weight regulation.

Design, Setting, and Participants: Ten young women with T1DM were studied in this 2-wk prospective, balanced crossover-design study at the University of California, Davis.

Intervention: Participants received either a single injection of regular + NPH insulin (R+N) or two mealtime injections of Lispro insulin in randomized order on 2 separate days. Meal composition and total insulin administered were the same on both treatment days.

Main Outcome Measures: Plasma glucose, insulin, leptin, and ghrelin concentrations were monitored over the 10-h study period.

Results: Lispro produced two distinct mealtime peaks of insulin, compared with one prolonged rise with R+N. Lispro reduced postprandial hyperglycemia and total glucose area under the curve. Leptin increased more on the Lispro (2.7 ± 0.7 vs. 0.7 ± 0.5 ng/ml, P = 0.02). Ghrelin was more suppressed after lunch with Lispro (P = 0.004).

Conclusions: Injection of Lispro insulin with meals produces more physiological insulin patterns, better glucose control, and improved leptin and ghrelin regulation than R+N. More closely mimicking normal insulin, leptin, and ghrelin responses to meals with fast-acting insulin may have implications for body weight regulation in T1DM.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
K. E. Foster-Schubert, J. Overduin, C. E. Prudom, J. Liu, H. S. Callahan, B. D. Gaylinn, M. O. Thorner, and D. E. Cummings
Acyl and Total Ghrelin Are Suppressed Strongly by Ingested Proteins, Weakly by Lipids, and Biphasically by Carbohydrates
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1971 - 1979.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
K. Hassan, L. M. Rodriguez, S. E. Johnson, S. Tadlock, and R. A. Heptulla
A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes
Pediatrics, March 1, 2008; 121(3): e466 - e472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. E Arsenault, P. J Havel, D. L. de Romana, M. E Penny, M. D Van Loan, and K. H Brown
Longitudinal measures of circulating leptin and ghrelin concentrations are associated with the growth of young Peruvian children but are not affected by zinc supplementation
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1111 - 1119.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society